Literature DB >> 2482743

The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition.

M W Makgoba, M E Sanders, S Shaw.   

Abstract

No process is more central to T-lymphocyte function than cell-cell adhesion, yet it is only recently that interest in lymphocyte adhesion has burgeoned. Neglect of adhesion is particularly surprising since immunologists are surrounded by a veritable sea of adhesive interactions of lymphocytic cells: transformed lymphocytes grow in aggregates, stimulated lymphocytes aggregate and T cells conjugate with their targets. In retrospect, it is obvious that all lymphocyte adhesion (both antigen-specific and seemingly non-specific adhesive interactions) has to be based on specific receptor-ligand interactions. In this review Malegapuru Makgoba, Martin Sanders and Stephen Shaw focus primarily on the two molecular pathways of lymphocyte adhesion that have been shown to play a critical role in facilitation of antigen-specific recognition, namely CD2 and its ligand, lymphocyte function associated antigen-3 (LFA-3), and LFA-1 and its ligand, intercellular adhesion molecule-1 (ICAM-1). A variety of excellent recent reviews have dealt with this and related aspects of T-cell adhesion. Of particular interest is the review that follows in this issue: it deals with the CD44 molecule which has also been implicated in both adhesion and activation of T cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482743     DOI: 10.1016/0167-5699(89)90039-X

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  58 in total

Review 1.  The role of adhesion molecules in endothelial cell accessory function.

Authors:  J R Westphal; R M de Waal
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

2.  Hodgkin's cells express a novel pattern of adhesion molecules.

Authors:  P A Ellis; D N Hart; B M Colls; J C Nimmo; J E MacDonald; H B Angus
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

3.  Adhesion molecules and IL-1 costimulate T lymphocytes in the autologous MECLR in psoriasis.

Authors:  E Prens; K t Hooft-Benne; B Tank; J Van Damme; T van Joost; R Benner
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

Review 4.  Strategies for treating liver metastasis from gastric cancer.

Authors:  Yoshihiro Kakeji; Masaru Morita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

5.  ICAM-1 expression in normal liver.

Authors:  S G Hubscher; D H Adams
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

6.  Influence of FK 506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study.

Authors:  A W Thomson; M Nalesnik; K Abu-Elmagd; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

7.  New monoclonal antibodies in CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues.

Authors:  D J Anstee; B Gardner; F A Spring; C H Holmes; K L Simpson; S F Parsons; G Mallinson; S M Yousaf; P A Judson
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

8.  Analysis of adhesion molecules in the immunopathogenesis of giant cell arteritis.

Authors:  S O Wawryk; H Ayberk; A W Boyd; J Rode
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

9.  The expression and cellular distribution of adhesion molecules CD2/LFA-3 and ICAM-1/LFA-1 on mononuclear cells in squamous cell carcinoma of the head and neck.

Authors:  J Kornfehl; C Neuchrist; M C Grasl; K Ehrenberger; D Kraft; O Scheiner
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

10.  High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.

Authors:  E Roussel; M C Gingras; E A Grimm; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.